$PLTR

Palantir Shares Fall Over 5% Despite 96% Revenue Growth as Contract Momentum Raises Concerns

Palantir Technologies (PLTR) reported Q3 revenue of $2.31B, up 96% YoY, beating expectations. US commercial revenue grew 148% to $984M, surpassing government revenue. Despite raising full-year guidance to over $8.53B, shares fell 5% premarket due to concerns over slowing total contract value growth of 6%.

Original reporting
Published Nov 3, 2026, 2:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 3:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Palantir Shares Fall Over 5% Despite 96% Revenue Growth as Contract Momentum Raises Concerns — source image
Decision brief

The 30-second read

$PLTRBearishMed
01

Why it matters

The key trading tension is that revenue and guidance improved, but the forward-looking contract-signing indicator (TCV) decelerated sharply, driving the premarket selloff.

02

Market read

Traders should monitor whether the market treats TCV deceleration as a leading indicator for future revenue growth, potentially overriding the raised guidance.

03

What to watch

The article does not quantify backlog, renewal rates, or contract duration; investors may be over-weighting a single-quarter TCV deceleration versus longer-term conversion.

Relevance 8/10Novelty 8/10Timing: premarket today, immediately ahead of the regular-session open

Background

Palantir reported a strong Q3 with rapid US commercial growth and raised full-year revenue outlook, while investors focused on slowing total contract value (TCV) growth.

Company-level read

Ticker impact

$PLTRBearishHigh confidence
Context

Palantir shares fell more than 5% premarket after Q3 revenue jumped 96% and full-year revenue guidance was raised, but TCV growth slowed to 6%.

Expected impact

Likely continued downside pressure or choppy trading as investors reprice forward revenue durability tied to weaker TCV momentum.

Evidence & confidence

The article highlights a specific investor focus shift from earnings/guidance to contract momentum, citing TCV growth decelerating from 49% to 6%.

Market effects

Reinforces that AI software names can trade on contract-signing quality, not just revenue growth, potentially pressuring similar high-expectation enterprise AI stocks.

Primarily impacts US-listed AI software sentiment, with premarket repricing likely spilling into broader tech risk appetite at the open.

Limited direct global spillover, but it can influence international investors’ read-through on US enterprise AI contract cycles.

Counterpoint

The guidance beat and rising US commercial revenue could still indicate improving monetization, and TCV timing may not translate immediately into revenue.

Key entities

  • Palantir Technologies

    US AI and data analytics company whose shares fell premarket despite Q3 beats and raised revenue guidance, due to slower TCV growth.

Related articles

$PLTRHighAI 8/10

Palantir Falls 4% as Contract Growth Slows Despite Demand “Much Larger Than We Can Service”

Palantir Technologies (PLTR) shares fell 4% after Q3 revenue rose 96% to $2.31B, but total contract value grew just 6% to $2.92B. U.S. commercial remaining deal value increased 4% from June. CEO Alex Karp attributed the slowdown to high demand. Analysts note shorter contract durations may be the cause. Palantir raised its 2026 revenue guidance to $8.53B. ServiceNow (NOW) and Snowflake (SNOW) also reported mixed contract growth.

$PLTRHighAI 8/10

Burry vs Karp: One Year Later, Who Actually Won the Palantir Fight?

Michael Burry's short position on Palantir (PLTR) has seen mixed results. Palantir's stock fell 3.2% over a year, trailing the S&P 500's 10.1% gain. Burry closed his put options but maintained short positions. Palantir's Q3 revenue beat estimates, with strong growth in U.S. commercial revenue. However, valuation concerns remain, with PLTR trading at high multiples. Karp's fundamentals argument is strong, but Burry's valuation critique persists.